Ngā hua rapu - Destini Gibbs-Curtis

Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes mā Hanna Scholze, Regan E. Stephenson, Raymond Reynolds, Shivem B. Shah, Rishi Puri, Scott D. Butler, Vicenta Trujillo-Alonso, Matthew R. Teater, Herman van Besien, Destini Gibbs-Curtis, Hideki Ueno, Salma Parvin, Anthony Letai, Susan Mathew, Ankur Singh, Ethel Cesarman, Ari Melnick, Lisa Giulino‐Roth